Overview

High-concentration Small-volume Versus Low-concentration Large-volume Iodine Solution for Esophageal Chromoendoscopy

Status:
Recruiting
Trial end date:
2024-04-30
Target enrollment:
0
Participant gender:
All
Summary
This clinical trial aims to test the participants' tolerance for different concentration iodine solutions during esophageal chromoendoscopy. The main question it aims to answer is: Under the same iodine dosage, do the participants have the same tolerance for 1% and 5% iodine solutions? Participants will be asked to score based on pain and discomfort and describe symptoms and corresponding location at 5 minutes (only for unanesthetized participants) and 30 minutes after chromoendoscopy.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Xijing Hospital of Digestive Diseases
Collaborators:
Air Force 986 Hospital
Ankang Central Hospital
The First Affiliated Hospital of ShiheziI University
Xi'an International Medical Center Hospital
Xianyang Central Hospital (the second people's Hospital of Xianyang City)
Treatments:
Cadexomer iodine
Iodine
Lugol's solution
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- Patients undergoing esophageal Lugol's iodine chromoendoscopy.

- Age ≥ 18

Exclusion Criteria:

- Patients allergic to iodine or with hyperthyroidism;

- Patients with esophageal varices, esophageal ulcer or other conditions inadvisable for
Lugol chromoendoscopy;

- Patients with severe gastroesophageal reflux disease or reflux symptoms which may
interfered with the outcome measures of current study;

- Patients with postoperative esophageal stenosis affecting endoscopic observation;

- Patients who could not cooperate with the observation and data collection including
patients with mental disorders, severe neurosis, dysgnosia or communication disorder;

- Patients with advanced-stage tumors;

- Patients after upper gastrointestinal surgery;

- Patients who do not agree to sign informed consent forms or follow the trial
requirement.